iwNHL 2018 | Precision medicine in lymphoma
Anas Younes, Davide Rossi and Thomas Witzig
• 21 Sep 2018
Precision medicine is improving outcomes, toxicity and disease management in trials and routine clinical practice. Anas Younes, MD, from the Memorial Sloan Kettering Cancer Center, New York City, NY, chaired a discussion at the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2018 meeting held in Nice, France, on how precision medicine is being used to improve lymphoma treatment. Dr Younes was joined by Thomas Witzig, MD, of Mayo Clinic, Rochester, MI, and Davide Rossi, MD, from the Institute of Oncology Research, Bellinzona, Switzerland. Topics covered included: current precision medicine clinical trials, using ctDNA to guide therapy, precision medicine across histologic subtypes, and precision medicine in follicular lymphoma.
